Together, these data indicate the contribution of FOXO-dependent signaling to synoviocyte hyperproliferation, thereby highlighting the potential of therapeutically exploiting FOXO3-dependent RA pathogenesis. The gene discussed is FOXO3; the disease is rheumatoid arthritis.